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Summary A new human tumour cell line (designated HX165c) has been established from an epithelioid
sarcoma presenting in a 28 year old male. The cells grew as an adherent monolayer with a doubling time of
38 h and had mainly epithelial morphology but with areas of mesenchymal-like cytoplasmic extensions. The
mixed epithelial-mesenchymal phenotype was also apparent by intermediate filament analysis which showed
reactivity to vimentin and keratin. The cells were tumorigenic in nude mice and aneuploid, possessing a mean
chromosome number of 65. In vitro cloning determinations gave colony-forming efficiencies of 0.01% in an
anchorage-independent soft agar assay and 34% in a monolayer anchorage-dependent assay. The cells were in
the mid-range for radiosensitivity of human tumour cells (surviving fraction at 2Gy of 0.39). In addition,
experiments utilising continuous low dose rate irradiation at 3.2cGymin-1, showed that the cells possessed
only a small capacity to recover from radiation damage (dose reduction factor at 1% cell survival of 1.15 for
150 versus 3.2cGymin-m). This cell line, being only the second we are aware of to be established from this
rare soft tissue sarcoma, should be useful in helping to ascertain the histogenesis of epithelioid sarcoma.
Epithelioid sarcoma was first recognised as a histologically
distinct sarcoma in 1970 (Enzinger, 1970). It is a rare tumour
accounting for only 1% to 2% of human soft tissue
sarcomas and most often presents in males from 20 to 40
years of age. The most common sites of origin are the
subcutaneous tissues of the distal parts of the limbs. The
histogenesis of this tumour is at present unknown although
there is some evidence that it is of synovial origin (Gabbiani
et al., 1972) with the tumour possibly being a variant of
synovial sarcoma (Mukai et al., 1985). Surgery provides the
main form of treatment with radiotherapy being important
as an adjuvant (e.g. Lindberg et al., 1981).
Representative in vitro cell lines of epithelioid sarcoma are
extremely rare; indeed we are only aware of one recently
published description of a cell line (Reeves et al., 1987). In
this study we describe the establishment of a new cell line
(designated HX 165c) grown from a recurrence presenting in
a 28 year old male caucasian. Intermediate filament analysis
has been performed to help elucidate the histogenesis of this
disease. In addition, by means of a clonogenic cell survival
assay, its radiosensitivity has been determined, at both a
high dose rate of 150cGymin-1 and at a continuous low
dose rate of 3.2cGymin- . As has been shown previously
(Mitchell et al., 1979a; b; Steel et al., 1986) irradiation at
dose rates of around 3cGymin-1 allows extensive recovery
of radiation damage by repair processes without cell cycle
effects or repopulation occurring. Such determinations
enable a good indication of the initial slope of the cell
survival curve to be obtained, a parameter of importance as
it is now clear that its steepness correlates with clinical
radioresponsiveness (Fertil & Malaise, 1981; Deacon et al.,
1984; Steel, 1988).
Materials and methods
Establishment of cell line
The cell line was established from a biopsy (taken in April
1985) of a penile lesion in a 28 year old male caucasian
presenting at the Royal Marsden Hospital. The tumour at
the time of biopsy was a recurrence (after radiotherapy and
chemotherapy regimes) of a previously diagnosed epithelioid
sarcoma. The patient died around 18 months after the
biopsy was taken.
The biopsy was held in ice-cold Ham's F12 medium
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containing penicillin (105 U1 1), streptomycin (100mg -1)
and neomycin (10mgl-1) for 2h. The specimen was then
finely chopped with crossed scalpels and rinsed in PBS. One-
half of the material of 2 mm2 was implanted subcutaneously
into 5 female nude (nu/nu) mice to establish xenografts. The
remaining half was disaggregated overnight at 37°C in
Ham's F12 medium containing 1 mgml-1 collagenase
(Boehringer-Mannheim). After centrifugation (100 g, 5 min),
single cells were seeded into parallel tissue culture flasks in
medium containing 15% foetal calf serum, and 2mM gluta-
mine in a 5% C°2, 5% 029 90% N2 atmosphere.
A cell line grew very slowly for a few months as an
adherent monolayer culture but then appeared to terminally
differentiate and die before passage was possible. In xeno-
graft, slow growing tumours appeared after 4 months. When
the tumours reached a size of about 1 cm diameter (about 9
months after biopsy) a cell line was initiated by enzymatic
disaggregation and culturing as above. However, for the
growth of these cells derived from xenograft, it was decided
to follow methods used for culturing keratinocytes (Rhein-
wald & Green, 1975), which we had been successful with in
establishing epithelial cell lines of human cervix carcinoma
(Kelland et al., 1987). Briefly, cells were grown in medium as
above but containing in addition, hydrocortisone at
0.4,ug ml-1, insulin at 5 pgml -1 and transferrin at 5 jgml -1
as well as a lethally irradiated (200 Gy of y-rays) feeder layer
of the Swiss mouse embryonic fibroblast line 3T3 added at
2 x 105 cells/25cm2 flask. The resulting cell line, designated
HX 165c, grew as an adherent monolayer culture and had
the same appearance as the original cell line. Mycoplasma
screening was performed routinely by staining with
Hoechst 33528 dye and examining under a fluorescent
microscope.
Population doubling time determination
Growth curves were constructed by seeding cells at low
density (5 x 104/25 cm2 flask) and feeding every 48 h. Cells in
triplicate flasks were then detached at 24 h intervals and
viable cells counted using lissamine green dye exclusion.
Intermediate filament analysis
A standard double-antibody technique using cells fixed on
slides with acetone/methanol was used to detect intermediate
filament proteins by immunofluorescence. Low molecular
weight cytokeratins were measured using CAM 5.2 (Makin et
al., 1984); neurofilaments, vimentin, desmin and desmoplakin
antibodies were obtained from Eurodiagnostics. In addition,
a monoclonal antibody (GCTM-1) raised in our department
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from human embryonal carcinoma cells, which stains the
nuclei of all human cells (Pera et al., 1988) was used as a
positive control for the presence of human cells. Rabbit anti-
mouse immunoglobulin conjugated with fluorescein and used
as the second layer antibody was obtained from Zymed and
Miles Inc.
Tumorgenicity of cultured cells in nude mice
Female nude (nu/nu) mice were given s.c. injections of
3 x106 cells suspended in 0.2ml culture medium. Tumori-
genicity was assessed in the 6th and 40th passages of growth
using 5 mice in each case. Resulting tumours were then
removed, sectioned in paraffin, and stained with haematoxy-
lin and eosin. In addition, serial transplantation of material
into other nude mice was attempted.
Cytogenetic analysis
This was performed using exponentially growing cells as
previously described (Kelland et al., 1987). Chromosomes
stained with Giemsa were counted from at least 30 meta-
phase spreads when the cells were at passage 30.
Colony forming efficiency CFE
CFE was determined both in monolayer and using an
anchorage independent soft agar assay using single cell
suspensions prepared by disaggregation with 0.02% EDTA
in 0.05% trypsin and filtration through a 20 im polyester
mesh. Assays were then carried out as previously described
for other human tumour cells (Kelland et al., 1987a, b,
Kelland & Steel, 1988, for monolayer assay; Courtenay &
Mills, 1978, Kelland & Steel, 1986, for soft agar assay).
Briefly, cells were seeded and incubated in growth medium
as above. For the monolayer assay, 2 x 105 feeder cells were
added per 60 mm plate whereas in the soft agar assay,
I x 104 cells/tube were added. After incubation (15 days in
monolayer assay and 22 days in soft agar assay) colonies
containing greater than 50 cells were scored.
Irradiation procedure
Single cells were plated out according to the monolayer
clonogenic assay and radiation survival determined using
60Co y-rays as previously described for other human tumour
cells (Kelland et al., 1987, 1988a, b). Briefly, cells were gassed
for 30 min with 5% CO2 5% 02, 90% N2 mixture, sealed
into boxes, incubated for 90 min at 37°C and then irradiated
either at a dose rate of 150cGymin-1 or at a continuous
low dose rate of 3.2cGymin-1. Cells were maintained at
37°C in growth medium throughout irradiation.
Statistical analysis
Radiation survival data represent the mean+s.d. of at
least three experiments. Survival curves have been fitted
using the incomplete repair model for survival under con-
tinuous irradiation (Thames, 1985).
Results
The cell line HX 165c has now been growing in tissue culture
for 15 months and has been passaged at least 60 times.
Figure 1 shows the phase contrast morphological properties
of the cells. The line appeared to contain mainly epithelial-
like polygonal cells but, in addition, more mesenchymal-like
spindle shaped cells were apparent. Both of these morpholo-
gical phenotypes appeared to be stable with repeated pass-
aging. The in vitro cell doubling time was 38h. The cells
were found to be free of mycoplasma contamination.
Figure 1 Colony morphology of HX 165c. Cells appear mainly
epithelial in appearance but interspersed with areas containing
spindle shaped mesenchymal-like cells. Cells are in their 15th
passage of growth. Phase-contrast microscopy ( x 160).
Immunocytochemistry
All cells were strongly positive for the expression of interme-
diate filaments of the vimentin type (a marker for cells of
mesenchymal origin) and cytokeratins (found in cells of
epithelial origin). Cells were negative for neurofilaments,
desmin and desmoplakins . In addition, all cells were positive
against the GCTM-1 monoclonal antibody found to be
specific for human cells.
Tumorigenicity
HX 165c cells when injected into nude mice at passage 6 or
40, resulted in the formation of tumours after 6 to 8 weeks.
The efficiency of tumour formation was high with 9 out of
10 injection sites producing a tumour. The tumours appeared
to be well vascularized and to contain little necrotic tissue.
These tumours were then serially transplantable in further
mice as a stable xenograft line. A histological comparison of
the tumours formed in nude mice with the original patient
biopsy is shown in Figure 2 (2a is original biopsy, 2b is
xenograft biopsy). Figure 2a shows the original biopsy to
contain large areas of invasive tumour containing
epithelioid-like cells with high mitotic activity. Figure 2b
shows the xenograft to contain areas of tumour of similar
epithelioid appearance.
Cytogenetic analysis
The mean chromosome number from 30 metaphase spreads
of HX 165c cells in passage 30 of growth was 65 +a standard
deviation of 14. G-banding and other detailed cytogenetic
analyses have not been determined.
Colony-forming efficiency and radiosensitivity
CFE values for cloning in soft agar were less than 0.01%
whereas in the monolayer cloning assay a value of 34+s.e. of
7% was obtained. Figure 3 shows radiation cell survival
curves (determined using the monolayer cloning assay) for
HX 165c at both a high and low radiation dose rate. At a
dose rate of 150cGymin 1 the curve appears to be con-
tinuously bending in shape. Irradiation at the low dose rate
of 3.2cGy min- results in a small shift in the curve to the
right. Cell survival parameters derived from these curves are
shown in Table I.
Discussion
The HX 165c cell line, established from a tumour biopsy
diagnosed as an epithelioid sarcoma, appears to broadly324 L.R. KELLAND & L. BINGLE
Table I Summary of radiation survival and recovery para-
meters for HX 165c
Dose-rate (cGyrmin -
Dose-rate dependence 150 3.2
(i) Multitarget model
Do(Gy) 1.48 +0.015 1.80 +0.0363
n 2.05 +0.099 1.62 +0.283
(ii) Linear quadratic model
a(Gy 1) 0.44 +0.0039 0.39 +0.0019
fl(Gy -2) 0.017+0.00047 0.011 +0.0013
SF2+ 0.39 0.43
DRF - 1.15 -
;- * i ; t W 'A (±) SE. (+) Surviving fraction at 2Gy. (a) DRF=dose
* - ** * * * . a * *$ *** ^ ** j * reduction factor [ratio of isoeffect (1% cell survival) doses at
150 versus 3.2 cGymin-1 dose-rates].
maintain the morphological, histological and immunohisto-
chemical properties of the disease. The line has been con-
firmed as of human cell type and to be tumorigenic in nude
mice. We are aware of only one other characterised cell line
representative of this rare tumour (Reeves et al., 1987). The
cell line (RM-HS1) shows a number of similar features to
HX 165c described herein. The lines both grew as adherent
monolayers and upon morphological examination, exhibited
mainly epithelial characteristics but with some areas of
mesenchymal-like cytoplasmic extensions. The RM-HSI line
has also been shown to contain elevated levels of epidermal
growth factor (EGF) receptors (Gusterson et al., 1985). EGF
receptor analysis has not as yet been performed with
HX 165c. Cytogenetic analysis has shown very similar mean
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Figure 2 Histology of sections of (a) tumour biopsy taken from 66 for RM-HSI, Reeves et al., 1987).
patient at the time when the resulting cell line was initiated and Intermediate filament analysis has further indicated that
(b) tumour arising in nude mice from s.c. injection of 3 x 106 both lines possess properties characteristic of a mixed
cells of HX 165c. Cell line was in its 40th passage of growth at epithelial-mesenchymal cell origin. Intermediate filament
the time of injection. H and E ( x250). analysis using monoclonal antibodies raised against vimentin
(a marker for mesenchymal cells) and keratin (a marker of
epithelial cells) (Osborn & Weber, 1982) indicated that both
types were present in the cell lines. For RM-HS1, while all
cells were vimentin positive, only approximately 40% were
positive against CAM 5.2, the antibody recognising keratin
filaments. In HX 165c, all cells were positive for both
vimentin and keratin. As CAM 5.2 only detects the acidic
low molecular weight keratins of Mr 39K, 43K and 50K
(Makin et al., 1984), the difference in keratin positivity
between the lines probably reflects variations in these low
molecular weight keratins. Alternatively, differences may be
due to in vitro passaging conditions, which have been shown
to play a role in intermediate filament expression (Virtanen
et al., 1981). These tissue culture findings lend support to the
current clinical histopathological view that epithelioid sarco-
mas probably exhibit coexpression of keratin and vimentin
(Chase et al., 1984; Miettinen & Damjanov, 1985).
Colony forming efficiency determinations revealed large
differences in cloning ability in soft agar (0.01%) compared
to an anchorage-dependent monolayer assay (34%). Very
low efficiencies using soft agar assays have been observed for
other tumour cell lines, particularly lines of epithelial origin
(e.g. Rupniak & Hill, 1980; squamous carcinomas of the
head and tongue, Rheinwald & Beckett, 1981; cervix carci-
noma, Kelland et al., 1987). Our studies using HX 165c
therefore add to the finding that tumorigenicity may not be
a prerequisite for high cloning efficiency in anchorage inde-
pendent assays.
To our knowledge this is the first time a cell line derived
0 2 4 6 8 10 12 14 16 from a human epithelioid sarcoma has been the subject of a
Radiation dose (Gy) radiobiological analysis. A comparison with over 20 other
Figure 3 Cell survival of HX 165c cells irradiated with 60Co y- human tumour cell lines investigated in our laboratory over
rays at high dose-rate (150cGymin-1) (0) and at a continuous the past few years (Steel et al., 1987; Steel, 1988 for reviews)
low dose-rate of 3.2cGymin-1 (A). Full lines are calculated by indicates that HX 165c, with a Do of 1.48 Gy. a of
fitting to the incomplete repair model (Thames, 1985). 0.44Gy-1 and a SF2 value of 0.38, falls into the mid-range
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of radiosensitivity. The SF2 value for human tumour cells
has been shown to be a good discriminator between resistant
and sensitive tumour types (Deacon et al., 1984). According
to this classification of radiosensitivity, HX 165c may be
assigned to Group C or D which contains the majority of
common solid neoplasms such as breast, cervix, bladder,
colorectal and pancreatic carcinomas.
Data obtained at the low dose rate of 3.2 cGymin-t
however, indicate that the cells possess only a small capacity
to recover from radiation damage (Figure 3, DRF of 1.15
from Table I). In our series of studies (Steel et al., 1987;
Steel, 1988 for reviews) using other human tumour cell types,
a range of DRF values from 1.0 to 2.1 was observed. The
DRF value of 1.15 derived for HX 165c is among the lowest
in that range. Although this value is derived from only one
tumour line, if such a low recovery capacity and hence steep
initial slope, was representative for epithelioid sarcoma
generally, radiotherapy, particularly hyperfractionation or
continuous low dose rate brachytherapy regimes, may be
applicable in clinical treatment.
HX 165c, which maintains mixed epithelial-mesenchymal
properties in culture representative of the clinical disease
should further prove useful for investigations of chemo-
sensitivity and the histogenesis of epithelioid sarcoma.
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